Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomed. 2017;7291-309.
Malhotra S, Dumoga S, Singh N. Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation. Wiley Interdiscip Rev: Nanomed Nanobiotechnol. 2022;14(3): e1776.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–24.
Afzal O, Altamimi AS, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, Mubeen B, Murtaza BN, Iftikhar S, Riaz N, Kazmi I. Nanoparticles in drug delivery: From history to therapeutic applications. Nanomaterials. 2022;12(24):4494.
Lopes J, Lopes D, Pereira-Silva M, Peixoto D, Veiga F, Hamblin MR, Conde J, Corbo C, Zare EN, Ashrafizadeh M, Tay FR. Macrophage cell membrane-cloaked nanoplatforms for biomedical applications. Small Methods. 2022;6(8):2200289.
Yusuf A, Almotairy AR, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as drug delivery systems: A review of the implication of nanoparticles physicochemical properties on responses in biological systems. Polymers. 2023;15(7):1596.
Fang C, Zhang M. Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine. J Controll Release: Off J Controll Release Soc. 2010;146(1):2.
Zhang J, Tang H, Liu Z, Chen B. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy. International journal of nanomedicine. 2017;8483-93.
Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16:1–33.
Park JY, Park S, Lee TS, Hwang YH, Kim JY, Kang WJ, Key J. Biodegradable micro-sized discoidal polymeric particles for lung-targeted delivery system. Biomaterials. 2019;1(218):119331.
Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res. 2009;26:235–43.
Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–51.
Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;1(99):28–51.
Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6):673–92.
Oh JY, Kim HS, Palanikumar L, Go EM, Jana B, Park SA, Kim HY, Kim K, Seo JK, Kwak SK, Kim C. Cloaking nanoparticles with protein corona shield for targeted drug delivery. Nat Commun. 2018;9(1):4548.
Saha K, Rahimi M, Yazdani M, Kim ST, Moyano DF, Hou S, Das R, Mout R, Rezaee F, Mahmoudi M, Rotello VM. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano. 2016;10(4):4421–30.
Chen D, Ganesh S, Wang W, Amiji M. Protein corona-enabled systemic delivery and targeting of nanoparticles. AAPS J. 2020;22:1–9.
Zou Y, Ito S, Yoshino F, Suzuki Y, Zhao Li, Komatsu N. Polyglycerol grafting shields nanoparticles from protein corona formation to avoid macrophage uptake. ACS Nano. 2020;14(6):7216–26.
Grenier P, de Oliveira Viana IM, Lima EM, Bertrand N. Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo. J Control Release. 2018;10(287):121–31.
Fam SY, Chee CF, Yong CY, Ho KL, Mariatulqabtiah AR, Tan WS. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials. 2020;10(4):787.
Jin Q, Deng Y, Chen X, Ji J. Rational design of cancer nanomedicine for simultaneous stealth surface and enhanced cellular uptake. ACS Nano. 2019;13(2):954–77.
Schöttler S, Becker G, Winzen S, Steinbach T, Mohr K, Landfester K, Mailänder V, Wurm FR. Protein adsorption is required for stealth effect of poly (ethylene glycol)-and poly (phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372–7.
Hadjesfandiari N, Parambath A. Stealth coatings for nanoparticles: Polyethylene glycol alternatives. InEngineering of biomaterials for drug delivery systems 2018 Jan 1 (pp. 345-361). Woodhead Publishing.
Rattan R, Bhattacharjee S, Zong H, Swain C, Siddiqui MA, Visovatti SH, Kanthi Y, Desai S, Pinsky DJ, Goonewardena SN. Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting. Bioorg Med Chem. 2017;25(16):4487–96.
Tse WH, Gyenis L, Litchfield DW, Zhang J. Cellular interaction influenced by surface modification strategies of gelatin-based nanoparticles. J Biomater Appl. 2017;31(7):1087–96.
Sheng Y, Yuan Y, Liu C, Tao X, Shan X, Feng Xu. In vitro macrophage uptake and in vivo biodistribution of PLA–PEG nanoparticles loaded with hemoglobin as blood substitutes: Effect of PEG content. J Mater Sci - Mater Med. 2009;20:1881–91.
Hu Y, Hou Y, Wang H, Hua Lu. Polysarcosine as an alternative to PEG for therapeutic protein conjugation. Bioconjug Chem. 2018;29(7):2232–8.
Zhang F, Liu M-R, Wan H-T. Discussion about several potential drawbacks of PEGylated therapeutic proteins. Biol Pharm Bull. 2014;37(3):335–9.
Pannuzzo M, Esposito S, Wu LP, Key J, Aryal S, Celia C, Di Marzio L, Moghimi SM, Decuzzi P. Overcoming nanoparticle-mediated complement activation by surface PEG pairing. Nano Lett. 2020;20(6):4312–21.
Xuan M, Shao J, Li J. Cell membrane-covered nanoparticles as biomaterials. Natl Sci Rev. 2019;6(3):551–61.
Piao J-G, Wang L, Gao F, You Y-Z, Xiong Y, Yang L. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano. 2014;8(10):10414–25.
Hu C-M, Zhang Li, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci. 2011;108(27):10980–5.
Pitchaimani A, Nguyen TDT, Aryal S. Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. Biomaterials. 2018;160:124–37.
Nguyen TD, Aryal S, Pitchaimani A, Park S, Key J, Aryal S. Biomimetic surface modification of discoidal polymeric particles. Nanomed: Nanotechnol Biol Med. 2019;16:79–87.
Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, Zhou J, Kim HW, Gao W, Lu W, Zhang L. Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials. 2016;1(111):116–23.
Fang RH, Hu C-M, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14(4):2181–8.
Zhang Y, Cai K, Li C, Guo Q, Chen Q, He X, Liu L, Zhang Y, Lu Y, Chen X, Sun T. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy. Nano Lett. 2018;18(3):1908–15.
Patel P, Hanini A, Shah A, Patel D, Patel S, Bhatt P, Pathak YV. Surface modification of nanoparticles for targeted drug delivery. Springer International Publishing; 2019; pp. 19-31.
Ben-Akiva E, Meyer RA, Yu H, Smith JT, Pardoll DM, Green JJ. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal. Sci Adv. 2020;6(16):eaay9035.
Pawar D, Mangal S, Goswami R, Jaganathan KS. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur J Pharm Biopharm. 2013;85(3):550–9.
Verissimo TV, Santos NT, Silva JR, Azevedo RB, Gomes AJ, Lunardi CN. In vitro cytotoxicity and phototoxicity of surface-modified gold nanoparticles associated with neutral red as a potential drug delivery system in phototherapy. Mater Sci Eng, C. 2016;65:199–204.
Key J, Aryal S, Gentile F, Ananta JS, Zhong M, Landis MD, Decuzzi P. Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging. Biomaterials. 2013;34:5402–10.
Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly (l-lysine)—poly (ethylene glycol)—folate conjugate. Langmuir. 2005;21(19):8852–7.
Villanueva-Flores F, Castro-Lugo A, Ramírez OT, Palomares LA. Understanding cellular interactions with nanomaterials: Towards a rational design of medical nanodevices. Nanotechnology. 2020;31(13):132002.
Cooley M, Sarode A, Hoore M, Fedosov DA, Mitragotri S, Gupta AS. Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale. Nanoscale. 2018;10(32):15350–64.
Shi L, Zhang J, Zhao M, Shukun Tang Xu, Cheng WZ, Li W, Liu X, Peng H, Wang Q. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13(24):10748–64.
Comments (0)